SALT LAKE CITY, April 11, 2011 /PRNewswire/ --
TechniScan's (OTC BB: TSNI) novel breast ultrasound
technology and clinical results will be featured at the American
Institute of Ultrasound Medicine's annual conference in
New York this week.
As part of an educational session on advanced breast ultrasound
imaging, Michael Andre, Ph.D.,
director of an ongoing clinical study at the University of California, San Diego Moores Cancer
Center that enlists TechniScan's automated Warm Bath Ultrasound
(WBU) technology, will be leading the discussion and explaining the
latest results of the WBU ultrasound system.
TechniScan's WBU system not only employs the well-known
properties of reflection ultrasound but also maps the breast by
sending transmission ultrasound waves through it, which
significantly improves the clinical information and may allow a
radiologist to determine whether a breast lesion is a cyst, a
benign fibroademona or a malignancy – without a biopsy.
Two of the world's leading experts on transmission ultrasound
and the mathematics of inverse scattering, James Wiskin, Ph.D., a TechniScan founder and
adjunct professor at the University of
Utah Department of Bioengineering, along with his colleague
David Borup, Ph.D., are co-authors
on the study. Wiskin will also be participating in the New York session.
"This conference is a great opportunity for other physicians and
scientists to learn of the scientific and medical advances the
TechniScan system demonstrates," said Andre.
The goal of the new technology is to improve breast imaging
using a quick and practical approach for examining the entire
breast in detail and looking inside the breast for abnormalities.
The images are captured using a comfortable, radiation-free method
as a woman lies prone on an examination table and ultrasound is
directed, using warm water as a coupling medium, into the woman's
breast tissue.
The UC San Diego Moores Cancer Center has scanned over 150 women
in the two years of the study and will be sharing detailed
comparisons of the WBU technology to sonography and MRI during the
education session where results to date show very high
correlation.
About TechniScan
TechniScan, Inc. is a medical device company engaged in the
development and commercialization of a non-invasive imaging tool
designed to provide physicians with automated ultrasound images of
the human breast. TechniScan's Warm Bath Ultrasound™ (WBU™) imaging
device is limited by U.S. law to investigational use unless, and
until, cleared by the FDA. For more information, please visit
www.tsni.com.
Forward Looking Statements
Certain statements in this press release that are not
historical facts are "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements may be identified by the use of words such as
"anticipate, "believe," "expect," "future," "may," "will," "would,"
"should," "plan," "projected," "potential," "intend," and similar
expressions. Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, performance or achievements of TechniScan, Inc.
(the "company") to be materially different from those expressed or
implied by such forward-looking statements. The company's future
operating results are dependent upon many factors, including risk
factors discussed in the company's periodic filings with the
Securities and Exchange Commission, which are available for review
at www.sec.gov, including the company's Annual Report on Form 10-K
filed on March 22, 2010. The company
undertakes no obligation to update any forward-looking statement,
whether as a result of new information, future events or
otherwise.
Media Contact:
Tracy Harden
Marketing Communications
435-640-1065
tharden@tsni.com
SOURCE TechniScan